journal article·2025-02-05

Halting Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Neuron-Inhibitory Liposomes

Zhiqin Wang, Jingyan Wei, Jingyi Sun, Naishi Li, Jingyuan Liu, Yang Huang, Guangjun Nie, Yiye Li

Nano Letters· Volume 25· Issue 5
Publisher page

Abstract

Pancreatic ductal adenocarcinoma (PDAC) remains an aggressive malignancy. The occurrence of perineural invasion is associated with neuropathic pain and poor prognosis of PDAC, underscoring the active participation of nerves and their potential as therapeutic targets. Lidocaine is a local anesthetic with antitumor properties in some tumors in the clinic. Nevertheless, its clinical application in PDAC is constrained by the insufficient tumor accumulation and potential neurovirulence associated with a high-dose regimen. Here, a tumor microenvironment-targeted and -responsive liposome was constructed to deliver lidocaine for restraining PDAC growth through single nerve regulation. By conjugation of a collagen binding peptide, the pH-responsive liposomes accumulate in the extracellular matrix. The released lidocaine selectively reduces neurite length and density, thereby indirectly halting the progression and metastasis of PDAC in an orthotopic mouse model without noticeable adverse effects. This study highlights the potential of anesthetic-based nanomodulation of crosstalk between nerve and tumor cells for PDAC treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cancer, Stress, Anesthesia, and Immune Response · Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Pharmaceutical Sciences

Jilin University

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience

National Center for Nanoscience and Technology

College of Materials Science and Optoelectronic Technology

University of Chinese Academy of Sciences

Funding

National Key Research and Development Program of China · Natural Science Foundation of Beijing Municipality · China Academy of Chinese Medical Sciences

References (42)

Show source-provided references
1. 10.1136/bmj-2022-07399510.1136/bmj-2022-073995 ↗
2. 10.1038/nrc313110.1038/nrc3131 ↗
3. 10.1016/j.cell.2023.02.00210.1016/j.cell.2023.02.002 ↗
4. 10.1158/0008-5472.CAN-08-181010.1158/0008-5472.CAN-08-1810 ↗
5. 10.1016/j.ccell.2017.11.00710.1016/j.ccell.2017.11.007 ↗
6. 10.1158/2159-8290.CD-18-139810.1158/2159-8290.CD-18-1398 ↗
7. 10.1038/nrgastro.2015.16610.1038/nrgastro.2015.166 ↗
8. 10.1158/0008-5472.CAN-13-205010.1158/0008-5472.CAN-13-2050 ↗
9. 10.1053/j.gastro.2020.04.03710.1053/j.gastro.2020.04.037 ↗
10. 10.1073/pnas.151260311310.1073/pnas.1512603113 ↗
11. 10.1038/s41467-023-38128-x10.1038/s41467-023-38128-x ↗
12. Ketterer K. · Clin. Cancer Res. · 2003 · 9 · 5127
13. 10.1038/ncomms1513010.1038/ncomms15130 ↗
14. 10.1097/ALN.0b013e3181a913e110.1097/ALN.0b013e3181a913e1 ↗
15. 10.1016/j.tcm.2010.03.00210.1016/j.tcm.2010.03.002 ↗
16. 10.3389/fonc.2021.66974610.3389/fonc.2021.669746 ↗
17. 10.3389/fphar.2022.77089210.3389/fphar.2022.770892 ↗
18. 10.1016/j.celrep.2023.11343710.1016/j.celrep.2023.113437 ↗
19. 10.1016/j.bja.2020.03.03410.1016/j.bja.2020.03.034 ↗
20. 10.1016/j.bja.2022.03.03110.1016/j.bja.2022.03.031 ↗
21. 10.3390/jcm1112354310.3390/jcm11123543 ↗
22. 10.3748/wjg.v27.i18.210510.3748/wjg.v27.i18.2105 ↗
23. 10.1186/s13045-017-0448-510.1186/s13045-017-0448-5 ↗
24. 10.1073/pnas.190862611610.1073/pnas.1908626116 ↗
25. 10.1016/j.biomaterials.2022.12194510.1016/j.biomaterials.2022.121945 ↗
26. 10.1016/j.nantod.2023.10199310.1016/j.nantod.2023.101993 ↗
27. 10.1016/j.nantod.2022.10153310.1016/j.nantod.2022.101533 ↗
28. 10.1038/s41467-018-05906-x10.1038/s41467-018-05906-x ↗
29. 10.1021/acsnano.0c0886010.1021/acsnano.0c08860 ↗
30. 10.1093/rb/rbad04510.1093/rb/rbad045 ↗
31. 10.3109/10717544.2014.88246910.3109/10717544.2014.882469 ↗
32. 10.1016/j.ajps.2017.05.00810.1016/j.ajps.2017.05.008 ↗
33. 10.1016/j.jconrel.2015.12.00610.1016/j.jconrel.2015.12.006 ↗
34. 10.1016/0378-5173(93)90389-W10.1016/0378-5173(93)90389-W ↗
35. 10.1073/pnas.090336910610.1073/pnas.0903369106 ↗
36. 10.1016/j.nantod.2023.10181410.1016/j.nantod.2023.101814 ↗
37. 10.1038/nrc.2016.3810.1038/nrc.2016.38 ↗
38. 10.1126/sciadv.aay197110.1126/sciadv.aay1971 ↗
39. 10.1038/s41551-023-01019-z10.1038/s41551-023-01019-z ↗
40. 10.1007/s10853-022-07447-710.1007/s10853-022-07447-7 ↗
41. 10.1016/j.ejpb.2010.02.00710.1016/j.ejpb.2010.02.007 ↗
42. 10.1038/s41551-022-00909-y10.1038/s41551-022-00909-y ↗